Paul R. DeStefano provides strategic-planning counsel related to the formation, finance and operations of start-up companies in the life sciences industry. He regularly acts on behalf of US companies and investors in accessing technology and markets in Europe and Asia, and advises Japanese, German, British, French, Korean and Swiss companies in accessing US markets and capital. He also regularly advises US and European academic institutions in licensing, company formation and funding issues.
In his more than 40 years of international practice and more than 30 years of concentrating in the life sciences, Paul has represented US companies in raising billions of dollars through strategic alliances with foreign investors and collaborators. He has been involved as counsel in the founding of almost 200 life sciences companies around the world and in more than 40 initial public offerings (IPOs). Paul also serves as an advisor to a number of foreign investment banks and funds with respect to potential investments in the United States and regularly sits as an expert witness with respect to the valuation of intellectual property.
Paul speaks and writes regularly on legal and technology issues, particularly those related to the biological sciences. He also has been a lecturer on biotechnology and the law at Stanford Law School, UC Berkeley School of Law and Pennsylvania State University (Dickinson) School of Law, and has lectured on food and drug law at Santa Clara University School of Law and University of San Francisco School of Law.